Loading…
Reported covered position: Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013-2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SWARTHMORE COLLEGE via KING & SPALDING LLP
2026 · first_quarter · Q1
Issues affecting higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Source: Senate LDA
| SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.) |
| 18 |
| 2020–2024 |
| ACADIA HEALTHCARE | 16 | 2022–2026 |
| KIDNEY TRANSPLANT COLLABORATIVE | 16 | 2022–2026 |
| GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS | 14 | 2020–2023 |
| KANEKA PHARMA AMERICA, LLC | 14 | 2022–2025 |
| Amarin Pharma, Inc. | 12 | 2020–2024 |
| ATARA BIOTHERAPEUTICS, INC. | 10 | 2022–2024 |
| MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) | 9 | 2023–2026 |
| AMERICAN REGENT, INC. | 7 | 2020–2021 |
| EXAMWORKS | 7 | 2024–2026 |
| PRELUDEDX | 7 | 2023–2024 |
| AMERICAN MEDICAL TECHNOLOGIES | 6 | 2020–2021 |
| BONE GROWTH STIMULATOR COALITION (INFORMAL COALITION) | 6 | 2020–2021 |
| GREATER BALTIMORE COMMITTEE | 6 | 2025–2026 |
| MOLECULIGHT CORPORATION | 6 | 2025–2026 |
| VOICES OF ALZHEIMER'S, INC. | 6 | 2025–2026 |
| ACERA SURGICAL INC. | 5 | 2021–2022 |
| ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) | 4 | 2022–2023 |
| STOP THE WAIT COALITION | 4 | 2021 |
| COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION | 3 | 2021–2022 |
| SWARTHMORE COLLEGE | 3 | 2025–2026 |
| TAURX PHARMACEUTICALS LTD | 3 | 2023 |
| UNITED CDPAP, INC. | 3 | 2024–2025 |
| HINGE HEALTH | 2 | 2022 |
| SOLACE HEALTH | 2 | 2025 |
| ST. PETERSBURG COLLEGE FOUNDATION, INC. | 2 | 2024 |
| FLAGLER COLLEGE | 1 | 2024 |
BRIDGE for Young-Onset Alzheimer’s Disease Act of 2025
Client: VOICES OF ALZHEIMER'S, INC. · Firm: KING & SPALDING LLP
Advocacy related to Legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Dialysis-Related Amyloidosis Treatment Act of 2025
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Dialysis-Related Amyloidosis Treatment Act of 2025
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Preserving Patient Access to Long-Term Care Pharmacies Act
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
To designate the facility of the United States Postal Service located at 324 Washington Avenue, Suite 1 in Grand Haven, Michigan, as the "Ell Thomas Simantz Post Office Building".
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
To designate the facility of the United States Postal Service located at 324 Washington Avenue, Suite 1 in Grand Haven, Michigan, as the "Ell Thomas Simantz Post Office Building".
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Dialysis-Related Amyloidosis Treatment Act of 2024
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.
Dialysis-Related Amyloidosis Treatment Act of 2024
Client: KANEKA PHARMA AMERICA, LLC · Firm: KING & SPALDING LLP
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation.
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Modernizing Opioid Treatment Access Act
Client: ACADIA HEALTHCARE · Firm: KING & SPALDING LLP
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Organ Donation Clarification Act of 2023
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 4343 (118th Cong.) (2023-2024) - To amend the National Organ Transplant Act to clarify the definition of valuable consideration, to clarify that pilot programs that honor and promote organ donation do not violate that Act, and for other purposes.
Positioning the Election Assistance Commission for the Future Act of 2023
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S.1607 (118th Cong.) (2023-2024).
Small Business Growth Act
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Advocate on electronic health records and behavioral health Issues; Advocate on HR 1359, S.644 (Modernizing Opioid Treatment Access Act).
Organ Donation Clarification Act of 2021
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 3569, Organ Donation Clarification Act of 2021.
Advocacy for Medicare Secondary Payer issues; RAMP Act, H.R. 8063 (117th).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues.
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation (pending number assignment).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues; MEPA legislation (pending number assignment).
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues.
CLAIM Act
Client: ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) · Firm: KING & SPALDING LLP
Support of H.R. 4037(116) - Claims Licensing Advancement for Interstate Matters (CLAIM) Act
Organ Donation Clarification Act of 2021
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 3569, Organ Donation Clarification Act of 2021
Organ Donation Clarification Act of 2021
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 3569, Organ Donation Clarification Act of 2021
Organ Donation Clarification Act of 2021
Client: KIDNEY TRANSPLANT COLLABORATIVE · Firm: KING & SPALDING LLP
Advocacy on kidney transplant issues, H.R. 3569, Organ Donation Clarification Act of 2021
American Innovation and Choice Online Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
Ending Platform Monopolies Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
Platform Competition and Opportunity Act of 2021
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
ACCESS Act of 2021
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Advocacy for Medicare Secondary Payer issues; RAMP Act, H.R. 8063
Advocacy for Medicare Secondary Payer issues; RAMP Act, H.R. 8063
Advocacy for Medicare Secondary Payer issues; RAMP Act, H.R. 8063
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574)
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574)
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); access to CARES Act Provider Relief Fund
Long-Term Care Pharmacy Definition Act of 2021
Client: SENIOR CARE PHARMACY COALITION · Firm: KING & SPALDING LLP
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act (S.1574); Advocacy on Tricare pharmacy issues
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
Facilitating Innovative Nuclear Diagnostics Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on Medicare coverage of Amyloid PET, outpatient package payment and H.R. 4479 (117) and S.2609 (117), Facilitating Innovative Nuclear Diagnostics Act of 2021
CLAIM Act
Client: ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) · Firm: KING & SPALDING LLP
Support of H.R. 4037(116) - Claims Licensing Advancement for Interstate Matters (CLAIM) Act
CLAIM Act
Client: ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) · Firm: KING & SPALDING LLP
Support of H.R. 4037(116) - Claims Licensing Advancement for Interstate Matters (CLAIM) Act
CLAIM Act
Client: ASSOCIATION OF CLAIMS PROFESSIONALS (FORMERLY AAICP) · Firm: KING & SPALDING LLP
Support of H.R. 4037(116) - Claims Licensing Advancement for Interstate Matters (CLAIM) Act
Housing Is a Human Right Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on outpatient package payment and H.R. 3772 (116) and Medicare coverage of Amyloid PET
Housing Is a Human Right Act of 2021
Client: GE HEALTHCARE PHARMACEUTICAL DIAGNOSTICS · Firm: KING & SPALDING LLP
Advocacy on outpatient package payment and H.R. 3772
American Innovation and Choice Online Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
American Innovation and Choice Online Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
Ending Platform Monopolies Act
Client: COMPUTER & COMMUNICATIONS INDUSTRY ASSOCIATION · Firm: KING & SPALDING LLP
Advocacy related to national security issues arising from tech industry antitrust bills; H.R. 3849, the Augmenting Compatibility and Competition by Enabling Service Switching Act of 2021 or the ACCESS Act of 2021; H.R. 3826, the Platform Competition and Opportunity Act of 2021; H.R. 3816, the American Choice and Innovation Online Act; H.R. 3825, Ending Platform Monopolies Act
Advocacy related to Legislation to H.R. 6799 and eliminating SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Part D Coverage and reimbursement of long-term care pharmacy and H.R. 5031 and S. 3159. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2026 · first_quarter · Q1
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056, S. 3816 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2026 · first_quarter · Q1
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2026 · first_quarter · Q1
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · second_quarter · 2A
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SWARTHMORE COLLEGE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Issues affecting higher education.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocate on Tricare pharmacy Issues; MEPA Legislation. Advocate on Preserving Patient Access to Long-term Care Pharmacies Act (H.R. 5031).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · fourth_quarter · 4T
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Filing targets: HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2025 · fourth_quarter · Q4
IDRE Program Advocacy.
Filing targets: HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · fourth_quarter · Q4
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWARTHMORE COLLEGE via KING & SPALDING LLP
2025 · fourth_quarter · RR
Issues affecting higher education.
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · third_quarter · 3A
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · third_quarter · Q3
Lobbying on Medicare coverage issues
Filing targets: Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on Wound Care LCDs and payment rates; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 4056 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy on Kidney Transplant Issues; LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 4055 (119th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · third_quarter · Q3
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
EXAMWORKS via KING & SPALDING LLP
2025 · third_quarter · Q3
IDRE Program Advocacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · second_quarter · Q2
Lobbying on Medicare coverage issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on Wound Care LCDs; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy on Kidney Transplant Issues; Organ Donor Clarification Act. LOVE Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate for Amtrak Funding, SBA Funding, CHIPS Act Funding.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Small Business Administration (SBA)
EXAMWORKS via KING & SPALDING LLP
2025 · second_quarter · Q2
IDRE Program Advocacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on Hospital Reimbursement Issues and Maryland Payment Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · second_quarter · Q2
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
MOLECULIGHT CORPORATION via KING & SPALDING LLP
2025 · second_quarter · RR
Medicare Coverage Issues.
MARC COALITION via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388, and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocate for Amtrak - Funding for Projects.
Filing targets: HOUSE OF REPRESENTATIVES
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · first_quarter · Q1
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLACE HEALTH via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy regarding changing the landscape of healthcare in the US.
Filing targets: HOUSE OF REPRESENTATIVES
GREATER BALTIMORE COMMITTEE via KING & SPALDING LLP
2025 · first_quarter · RR
Advocate for Amtrak, Funding for Projects.
VOICES OF ALZHEIMER'S, INC. via KING & SPALDING LLP
2025 · first_quarter · RR
Legislation to eliminate SSDI waiting period for individuals with young onset Alzheimers
UNITED CDPAP, INC. via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy on NY State Medicaid Plan Amendment Issues related to CDPAP Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2025 · first_quarter · Q1
Part D Coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act. Advocacy on Tricare pharmacy Issues; MEPA Legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES
PHOTOCURE, INC. via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy around Hospital Reimbursement and Treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocate on Wound Care LCDs; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy on Kidney Transplant Issues; Organ Donor Clarification Act. LOVE Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocacy in support of Medicare Coverage for Dialysis-Related Amyloidosis (DRA) Treatment. H.R. 8999 (118th Cong.).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
EXAMWORKS via KING & SPALDING LLP
2025 · first_quarter · Q1
IDRE Program Advocacy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocate on Healthcare Workforce Resilience Act and Safety from Violence for Healthcare Employees (SAVE) Act; FY 2026 Appropriations; Congressional Directed Funding Rules; Maryland payment rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2025 · first_quarter · Q1
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
SOLACE HEALTH via KING & SPALDING LLP
2025 · first_quarter · RR
Advocacy regarding changing the landscape of healthcare in the US.
MEDICARE ACCESS TO SKIN SUBSTITUTES COALITION (MASS COALITION) (INFORMAL) via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocate on Wound Care LCDs; 361 Process.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
EXAMWORKS via KING & SPALDING LLP
2024 · fourth_quarter · Q4
IDRE Program Advocacy.
UNITED CDPAP, INC. via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy on New York State Medicaid Plan Amendment Issues related to CDPAP Program.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
MARC COALITION via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 Modernizing Opioid Treatment Access Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Part D coverage and reimbursement of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act; Advocacy on Tricare pharmacy issues; MEPA legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy around hospital reimbursement and treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY TRANSPLANT COLLABORATIVE via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy on kidney transplant issues; Organ Donor Clarification Act. LOVE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KANEKA PHARMA AMERICA, LLC via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment; H.R. 8999.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVENTIST HEALTHCARE via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocate on Healthcare Workforce Resilience Act and Safety from Violence for Healthcare Employees (SAVE) Act; FY 2025 Appropriation; Congressional Directed Funding Rules.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATARA BIOTHERAPEUTICS, INC. via KING & SPALDING LLP
2024 · fourth_quarter · Q4
Advocacy related to healthcare, FDA, and biotechnology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXAMWORKS via KING & SPALDING LLP
2024 · fourth_quarter · RR
Support efforts of MCMC Services LLC and Network Medical Review Co. LLC in connection with the "No Surprises Act 26 U.S. Code 9816.
UNITED CDPAP, INC. via KING & SPALDING LLP
2024 · fourth_quarter · RR
Advocacy on State Medicaid plan amendment issues.
ATARA BIOTHERAPEUTICS, INC. via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocacy related to healthcare, FDA, and biotechnology
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
POINTCLICKCARE TECHNOLOGIES, INC. via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocacy around expanded use of integrated health information technology to improve coordination of care in the long term and post-acute care settings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MARC COALITION via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocacy for Medicare Secondary Payer Issues; RAMP Act, H.R. 3388 and S. 1607 (118th Cong.) (2023-2024), Appropriation Issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ACADIA HEALTHCARE via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocate on electronic health records and behavioral health Issues; Advocate on H.R. 1359, S.644 (Modernizing Opioid Treatment Access Act).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via KING & SPALDING LLP
2024 · third_quarter · Q3
Part D coverage of long-term care pharmacy and The Long-Term Care Pharmacy Definition Act; Advocacy on Tricare pharmacy issues; MEPA legislation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHOTOCURE, INC. via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocacy related to Bladder cancer treatment and blue light cystoscopy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MULTICARE HEALTH SYSTEM via KING & SPALDING LLP
2024 · third_quarter · Q3
Advocacy around hospital reimbursement and treatments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE